| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/22/2004 | US6752997 Process for preparing non-hygroscopic sodium valproate composition |
| 06/22/2004 | US6752986 Using vitamin b12 compound; controlling gene expression |
| 06/22/2004 | US6752981 Cyclic phosph(oramid)ate prodrugs having alcohol, amine, orthiol groups attached to the phosphorus in the c3n2p or c3o2p ring |
| 06/22/2004 | CA2256093C Topical pharmaceutical compositions for healing wounds |
| 06/22/2004 | CA2241894C Use of octoxyglycerin in a cosmetic and/or dermatological composition as active agent for the treatment of seborrhoea and/or acne |
| 06/22/2004 | CA2192596C 4-(6-fluoro-1,2-benzisoxazolyl)-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis, schizophrenia and anxiety |
| 06/22/2004 | CA2153422C Dehydrogenation processes and equipment therefor |
| 06/22/2004 | CA2126241C Sulphated polysaccharide, preparation thereof, pharmaceutical composition and use thereof |
| 06/22/2004 | CA2122022C Anti-explosion pads and their method of use |
| 06/22/2004 | CA2114113C Cardiac output probe assembly |
| 06/22/2004 | CA2104793C Pharmaceutical combination for the treatment of prostatic hyperplasia, containing a 5 alpha-reductase inhibitor and an antiandrogen |
| 06/22/2004 | CA2095523C Composition comprising a tramadol material and acetaminophen and its use |
| 06/22/2004 | CA2093502C Hydrazoadenosines |
| 06/22/2004 | CA2066945C Oral, cutaneous and intravaginal pharmaceutical compositions in the form of foam |
| 06/18/2004 | CA2452952A1 Compositions and medical devices utilizing bioabsorbable polymeric waxes |
| 06/17/2004 | WO2004051263A1 Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition |
| 06/17/2004 | WO2004051222A2 Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases |
| 06/17/2004 | WO2004050913A1 Treatment of huntington’s disease with epa |
| 06/17/2004 | WO2004050890A1 Process for producing macrolide compound |
| 06/17/2004 | WO2004050842A2 Atm kinase compositions and methods |
| 06/17/2004 | WO2004050837A2 Treatment of dna damage related disorders |
| 06/17/2004 | WO2004050833A2 Glyceraldehyde 3-phosphate dehydrogenase-s(gapds), a glycolytic enzyme expressed only in male germ cells,is a target for male contraception |
| 06/17/2004 | WO2004050752A1 Absorbent articles comprising supercritical fluid polymerized polymer______________________________________ |
| 06/17/2004 | WO2004050715A2 Tough polymers |
| 06/17/2004 | WO2004050706A2 Regulatory t-cells |
| 06/17/2004 | WO2004050689A2 Aza-peptides |
| 06/17/2004 | WO2004050681A2 Kinase modulators |
| 06/17/2004 | WO2004050678A2 Compounds resistant to metabolic deactivation and methods of use |
| 06/17/2004 | WO2004050677A1 Novel chemical compunds and their use |
| 06/17/2004 | WO2004050660A1 Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
| 06/17/2004 | WO2004050647A2 Polymorphic forms of dihydrochloride salts of cetirizine and processes for preparation thereof |
| 06/17/2004 | WO2004050645A1 Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes |
| 06/17/2004 | WO2004050643A2 Non-nucleoside reverse transcriptase inhibitors |
| 06/17/2004 | WO2004050640A1 Pyrimidine-sulfamides and their use as endothelian receptor antagonist |
| 06/17/2004 | WO2004050630A1 The use of aryl- and heteroaryl-substituted tetrahydroisoquinolines in the treatment of chronic and neuropathic pain, migraine headaches, and urge, stress and mixed urinary incontinence |
| 06/17/2004 | WO2004050629A2 The use of 4-phenyl substituted tetrahydroisoquinolines in the treatment of pain, migraine and urinary incontinence |
| 06/17/2004 | WO2004050628A1 The use of 4-phenyl-substituted tetrahydroisoquinolines in the treatment of pain, migraine headaches and urinary incontinence |
| 06/17/2004 | WO2004050621A2 Indol derivatives and their use as kinase inhibitors |
| 06/17/2004 | WO2004050616A2 Treatment of irritable bowel syndrome and nonulcer dyspepsia with substituted 2,3-benzodiazepines |
| 06/17/2004 | WO2004050615A2 Method of increasing neutrophil production using 2,3-benzodiazepines |
| 06/17/2004 | WO2004050614A2 Flavanols and procyanidins promote homeostasis |
| 06/17/2004 | WO2004050612A1 S-substituted n-1-[(hetero)aryl]alkyl-n′-[(hetero)aryl] alkylysothiocarbamides, method for the production thereof, physiologically active s-substituted n-1-[(hetero)aryl]alkyl-n′-[(hetero)aryl]alkylysothiocarbamides, a pharmaceutical compound and curing method |
| 06/17/2004 | WO2004050187A1 Use of hyaluronic acid for respiratory disorders or the upper airways |
| 06/17/2004 | WO2004050123A2 Concentrated liquid valdecoxib composition |
| 06/17/2004 | WO2004050122A1 Preventive or remedy for diseases caused by hyperglycemia |
| 06/17/2004 | WO2004050115A2 Combination treatment using exendin-4 and thiazolidinediones |
| 06/17/2004 | WO2004050110A1 Medicinal composition |
| 06/17/2004 | WO2004050107A1 A drop pill of treating and preventing from cardio-cerebral diseases and the process of producing thereof |
| 06/17/2004 | WO2004050101A2 Formulations useful against hepatitis c virus infections |
| 06/17/2004 | WO2004050100A1 Method for treating a tumor using a thermo-gelling chitosan composition |
| 06/17/2004 | WO2004050099A1 Method of stabilizing reduced nicotinamide adenine dinucleotide or reduced nicotinamide adenine dinucleotide phosphate |
| 06/17/2004 | WO2004050098A1 Freeze-dried preparation of stabilized anthracycline compound |
| 06/17/2004 | WO2004050097A1 Use of amphiphilic lipids for the preparation of a pharmaceutical composition for reducing tumor metastasis |
| 06/17/2004 | WO2004050096A2 Phosphoantigens for regulating an immune response |
| 06/17/2004 | WO2004050095A1 Use of a known substance for the treatment of cancer and bacterial and fungal infections |
| 06/17/2004 | WO2004050094A1 Use of levocetirizine for the treatment of persistent allergic rhinitis |
| 06/17/2004 | WO2004050093A1 Tiotropium-containing medicament combinations used for inhaling |
| 06/17/2004 | WO2004050092A1 Use of canthin-6-one, plant extracts containing same and derivatives thereof in the treatment of trypanosomiases |
| 06/17/2004 | WO2004050091A1 Phosphodiesterase 10a inhibitors |
| 06/17/2004 | WO2004050088A1 Jnk inhibitor |
| 06/17/2004 | WO2004050085A1 Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders |
| 06/17/2004 | WO2004050084A2 Ace-inhibitors having antioxidant and nitricoxid-donor activity |
| 06/17/2004 | WO2004050083A1 Iontophoretic delivery of rotigotine for the treatment of parkinson's disease |
| 06/17/2004 | WO2004050081A1 Treatments for benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases |
| 06/17/2004 | WO2004050080A1 Treatment of inflammatory disorders with 2,3-benzodiazepines |
| 06/17/2004 | WO2004050079A1 Composition comprising a carbamic acid derivative, its use as cosmetic and medicine |
| 06/17/2004 | WO2004050078A1 Remedy |
| 06/17/2004 | WO2004050077A1 Use of docosahexanoic acid as active substance for the treatment of lipodystrophy |
| 06/17/2004 | WO2004050076A1 Use of a histone deacetylase inhibitor for treating muscular dystrophies |
| 06/17/2004 | WO2004050075A1 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
| 06/17/2004 | WO2004050074A1 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
| 06/17/2004 | WO2004050073A1 Inhibitor of angiogenesis and kit for treating cancer comprising the inhibitor |
| 06/17/2004 | WO2004050072A1 Water-soluble composition containing coenzyme q10 |
| 06/17/2004 | WO2004050071A1 A method of preventing and/or treating asthma using parabromophenacyl bromide (pbpb) |
| 06/17/2004 | WO2004050070A2 Composition comprising pseudoephedrine and domperidone for preventing snoring |
| 06/17/2004 | WO2004050068A1 Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base |
| 06/17/2004 | WO2004050067A1 PHARMACEUTICAL FORMULATIONS COMPRISING β-2 ADRENORECEPTOR AGONISTS AND XANTHINES |
| 06/17/2004 | WO2004050062A2 Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier |
| 06/17/2004 | WO2004050061A1 Microemulsion composition for oral administration of biphenyldimethyldicarboxylate |
| 06/17/2004 | WO2004050060A1 Drug delivery system using subconjunctival depot |
| 06/17/2004 | WO2004050059A1 Low viscosity liquid dosage forms |
| 06/17/2004 | WO2004050058A2 Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base |
| 06/17/2004 | WO2004050057A2 An exopolysaccharides delivery system for active molecules |
| 06/17/2004 | WO2004050054A1 Dendrite elongation inhibitor for melanocyte and skin preparation for external use containing the same |
| 06/17/2004 | WO2004050053A1 Dendrite elongation inhibitor for melanocyte and skin preparation for external use containing the same |
| 06/17/2004 | WO2004050052A1 Oxazolidinones for cosmetic and pharmaceutical use in skin pathologies |
| 06/17/2004 | WO2004050051A1 Novel topical use of bis-arylimidazo[1,2-a]thiolane derivatives |
| 06/17/2004 | WO2004050040A2 Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5h-2,3-benzodiazepine and uses thereof |
| 06/17/2004 | WO2004050039A2 Spirocyclic ureas, compositions containing such compounds and methods of use |
| 06/17/2004 | WO2004050037A2 Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease |
| 06/17/2004 | WO2004050035A2 Benzimidazoles and analogs thereof as antivirals |
| 06/17/2004 | WO2004050033A2 Method of treating cancers |
| 06/17/2004 | WO2004050030A2 Anti-sickling agents |
| 06/17/2004 | WO2004050027A2 Materials and methods for treating ocular-related disorders |
| 06/17/2004 | WO2004050025A2 Combination of ibuprofen and oxycodone for acute pain relief |
| 06/17/2004 | WO2004050022A2 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/17/2004 | WO2004050021A2 Methods and compositions for applying pharmacologic agents to the ear |
| 06/17/2004 | WO2004050020A2 Improved opioid pharmaceutical compositions |
| 06/17/2004 | WO2004050019A2 Method and compositions for treating anxiety |
| 06/17/2004 | WO2004050018A2 Dicationic 2,5-diarylfuran aza-analogs as anti-protozoan agents |